H NMR (300 MHz, CDCl3) δ 8. 56 and 8.26 (2×br s, 1H), 7.71-7.77 (m, 1H), 7.15-7.52 (m, 12H), 6.69 (s, 1H), 5.42-5.50 (m, 1H), 3.19-3.97 (m, 2H) , 2.03-2.14 (m, 2H), 1.50-1.82 (m, 1H), 0.75-1.25 (m, 1H).
In batch synthesis of the target molecule
Synthesis of (S)-tert-butyl (1-hydroxy-3-phenylpropan-2-yl)carbamate 2 2
A solution of tert-butyl dicarbonate (1eq, 6.7mmol) in DCM (14 mL) was added dropwise to a solution of (S)-2-amino-3-phenylpropan-1-ol (1) (1eq, 6.7mmol) in a mixture of DCM (14 mL) and 1N NaOH (11 mL). The reaction mixture was then stirred at room temperature for 24 h, and the organic phase was separated. The aqueous layer was extracted with DCM (10 mL x 2). The combined organic layers were washed with water (10 mL x 1) and dried over Na2SO4. The solvent was evaporated in vacuo, to afford Synthesis of (S)-tert-butyl (1-(allyloxy)-3-phenylpropan-2-yl)carbamate 2 3
(S)-tert-butyl (1-hydroxy-3-phenylpropan-2-yl)carbamate
A solution of (S)-tert-butyl (1-hydroxy-3-phenylpropan-2-yl)carbamate (2) (1 eq, 6.7mmol), 4eq of allylbromide and DMF (0.1 M) was prepared in a flask and stirred under ice bath for 15 min. Synthesis of (S)-1-(allyloxy)-3-phenylpropan-2-amine 2 4
To the O-allyl amine 3 (0.39 mmol, 1 eq.) in 10 mL of dry CH2Cl2, TFA (3.94 mmol, 10 eq.) was added at 0 °C. Then the solution was stirred at r.t. for 18 h. After completion of the reaction (monitored by TLC), the excess of TFA was evaporated in vacuo. 10 mL of Na2CO3 (10 % aqueous solution) were added cautiously and the mixture was extracted with CH2Cl2 (2 × 10 mL). The combined organic layers were dried over anhydrous Na2SO4, filtered and concentrated to give a yellow oil. The crude product has been used in the next step without further purification. All analytical data are in agreement with literature. Synthesis of (S,Z)-ethyl 3-((1-(allyloxy)-3-phenylpropan-2-yl)amino)-4,4,4-trifluorobut-2-enoate 5
S5
O-allyl amine 4 (0.39 mmol,1 eq.) and ethyl 4,4,4-trifluoro-3-oxobutanoate (0.39 mmol, 1 eq.) were charged in a round bottomed flask under inert atmosphere and 4 Å molecular sieves and 10 mol% of ptoluensulfonic acid were added. Then dry EtOH (3.9 mL) was added, and the reaction was heated to reflux and stirred for 24 h. The mixture was diluted with DCM, and filtrated over celite. After solvent removal, the crude was purified by column chromatography (silica gel, hexanes/EtOAc = 8:2) to afford 5 as a colorless oil. 20 D= -207.81 (c=1.14 g/100 mL, CHCl3, λ=546 nm).
S6

S7
Synthesis of Ethyl 3-(((S)-1-(allyloxy)-3-phenylpropan-2-yl)amino)-4,4,4-trifluorobutanoate 6
Dry DMF or the appropriate catalytic chiral Lewis Base in the reported amount (Table 1) , and a 0.1 M solution of enamine 5 (1 eq.) in dry CH2Cl2 were introduced in a round bottomed flask under nitrogen atmosphere. The mixture was cooled down to the indicated temperature and HSiCl3 (3.5 eq.) was added to the reaction mixture. After the desired time, the reaction was quenched with a 4 M solution of NaOH until basic pH was reached. The resulting mixture was extracted with CH2Cl2, separated, and the organic phase dried over anhydrous Na2SO4. The solvent was removed under reduced pressure. The residue was purified by column chromatography (silica gel, hexanes/EtOAc = 98:2) to afford 6 as a colorless oil. In order to perform X-ray analysis, a sample of compound 6 was treated with an equimolar amount of HCl in Et2O. The product was slowly crystallized from a mixture of Et2O/hexane to afford light-yellow crystals of 6/HCl. Absolute configuration was determined to be (S,S).
A summary of the experimental details concerning the single-crystal X-ray diffraction study of 6/HCl is reported in Table S1 . X-ray data were collected on a Bruker Smart Apex CCD area detector equipped with fine-focus sealed tube operating at 50 kV and 30 mA, using graphite-monochromated Mo Kα radiation (λ = 0.71073 Å). Data reduction was made using SAINT programs; 3 absorption corrections based on multiscan were obtained by SADABS. 3 The structures were solved by SHELXS-97 4 and refined on F2 by full-matrix least-squares using SHELXL-14. 5 The program ORTEP-III 6 was used for molecular graphics. Synthesis of ethyl 4,4,4-trifluoro-3-(((S)-1-hydroxy-3-phenylpropan-2-yl)amino)butanoate 7
S11
Compound 6 (0.13 mmol, 1 equiv.) in EtOH (1.5 mL) was introduced in a two necks round-bottomed flask equipped with a condenser under N2 atmosphere. Pd(OAc)2 (0.03 mmol, 0.2 equiv.) and PPh3 (0.11 mmol, 0.88 equiv.) in EtOH (1.5 mL) were added to the solution, followed by 300 mg of SiO2. The reaction mixture was stirred at reflux for 20 h. After completion of reaction (monitored by TLC), the reaction mixture was diluted with DCM and filtered over celite. After solvent removal, the crude was purified by column chromatography (silica gel, hexane/EtOAc = 9:1) to afford 7 as a yellow oil. All analytical data are in agreement with literature. 
Synthesis of (S)-ethyl 3-(((S
)
Synthesis of (S)-ethyl 3-(((S)-1-(acetylthio)-3-phenylpropan-2-yl)amino)-4,4,4-trifluorobutanoate 9
3 A solution of dry DMF (0.5 mL) and crude 8 (0.22 mmol, 1eq) were subsequently added to a solution of CH3COSK (0.22 mmol, 1 eq) in dry DMF (0.5 mL) at 0 o C under N2. After 24h at room temperature, the mixture was diluted with water and extracted with AcOEt. The collected organic layers were dried (Na2SO4), filtered, concentrated under reduced pressure, the crude was purified by column chromatography (silica gel, n-hexane/AcOEt from 9:1 to 7:3) to afford 9 as a brown-yellow oil. 
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In flow synthesis of the target molecule
In flow synthesis of (S)-tert-butyl (1-hydroxy-3-phenylpropan-2-yl)carbamate 2 Two 2.5 mL Hamilton gastight syringes, containing A compound 1 (1 eq.) and Boc2O (1 eq.) in 2 mL of CH2Cl2 (0.25 M), and B aqueous NaOH (2 mL of a 1N solution in water) were connected by a PEEK tee junction to a 500 µL PTFE coil reactor. Both syringes fed the solutions ad 25 µL/min, giving a residence time of 10 minutes. The outcome of the reactor was connected to a Zaiput liquid liquid phase separator, to separate the organic phase from the aqueous phase. The organic phase was dried over sodium sulphate and evaporated under vacuo, to give pure product 2, as evaluated by 1 H NMR, in quantitative yield.
Two 2.5 mL Hamilton gastight syringes, containing A compound 1 (1 eq.) in 2 mL of THF (0.2 M), and B Boc2O (1 eq.) in 2 mL of THF were connected by a PEEK tee junction to a 500 µL PTFE coil reactor.
Both syringes fed the solutions ad 50 µL/min, giving a residence time of 5 minutes. The outcome of the reactor was collected into a vial containing saturated NH4Cl. The organic phase was separated, dried over sodium sulphate and evaporated under vacuo, to give pure product 2, as evaluated by In flow synthesis of (S)-tert-butyl (1-(allyloxy)-3-phenylpropan-2-yl)carbamate 3 S15 Two 2.5 mL Hamilton gastight syringes, containing A compound 2 (1 eq.) in 2 mL of THF (0.1 M), and 4 eq. of allylbromide, and B tBuOK (1.1 eq.) in 2 mL of THF were connected by a PEEK tee junction to a 500 µL PTFE coil reactor. Both syringes fed the solutions ad 25 µL/min, giving a residence time of 10 minutes. The outcome of the reactor was collected into a vial containing saturated NH4Cl. The organic phase was separated, dried over sodium sulphate and evaporated under vacuo, to give product 3 with a 75% conversion, evaluated by 1 H NMR, and confirmed as isolated yield.
Analytical data are in agreement with product obtained in batch procedure. Two 2.5 mL Hamilton gastight syringes, containing A compound 1 (1 eq.) in 2 mL of THF (0.2 M), and B Boc2O (1 eq.) in 2 mL of THF were connected by a PEEK tee junction to a 250 µL PTFE coil reactor.
Both syringes fed the solutions ad 25 µL/min, giving a residence time of 5 minutes. The outcome of the reactor was connected to another tee junction, fed by a 1 mL Hamilton gastight syringe C, containing allylbromide (0.8 mL of 2.4 M solution in THF, 4 equivalents) feeding at 10 µL/min. The outcome of this second tee was connected to another tee junction, fed by a 5 mL Hamilton gastight syringe, D, containing tBuOK (1.6 mL of a 0.33 M solution in THF, 1.1 equivalents) with a flow rate of 20 µL/min. The outcome of this third tee was connected to a 1000 µL PTFE coil reactor, with a total flow rate of 80 µL/min, and a S16 subsequent residence time of 12.5 minutes. The outcome of the reactor was collected into a vial containing saturated NH4Cl. The organic phase was separated, dried over sodium sulphate and evaporated under vacuo, to give product 3 with a 20% conversion, evaluated by 1 H NMR, and confirmed as isolated yield.
Analytical data are in agreement with product obtained in batch procedure.
In flow synthesis of (S)-1-(allyloxy)-3-phenylpropan-2-amine 4
Two 2.5 mL Hamilton gastight syringes, containing A compound 2 (1 eq.) in 2 mL of THF (0.1 M), and 4 eq. of allylbromide, and B tBuOK (1.1 eq.) in 2 mL of THF were connected by a PEEK tee junction to a 500 µL PTFE coil reactor. Both syringes fed the solutions ad 25 µL/min, giving a residence time of 10 minutes. The outcome of the reactor was collected into a vial containing 10% HCl, were it was stirred for further 40 min. Then 1N NaOH was added until basic pH was reached, the organic phase was separated, dried over sodium sulphate and evaporated under vacuo, to give product 4 with a 75% conversion, evaluated by 1 H NMR, and confirmed as isolated yield.
1H NMR (300 MHz, CDCl3) δ 7. 31 -7.06 (m, 5H), 5.98 -5.72 (m, 1H), 5.31 -5.04 (m, 2H) 
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Pictures of Flow reactors set up
